Credit Assignment (or Sale/Transfer)

Credit assignment in the context of the Pennsylvania Research and Development tax credit is the legal process by which a taxpayer who has earned a non-refundable tax credit for qualified research expenses, but lacks sufficient tax liability to utilize it, sells or transfers that credit to another Pennsylvania taxpayer for cash. This mechanism allows innovative businesses, particularly unprofitable startups, to monetize their tax benefits on the open market to fund continued operations while allowing purchasers to reduce their own state tax liabilities.

The Pennsylvania Research and Development (R&D) Tax Credit program, established under Article XVII-B of the Tax Reform Code of 1971, serves as a cornerstone of the Commonwealth’s economic development strategy. While the primary function of the credit is to incentivize investment in innovation by providing a direct offset against Corporate Net Income Tax (CNIT), Personal Income Tax (PIT), or Capital Stock and Franchise Tax (CSFT), its secondary utility through "Assignment" or "Sale" is perhaps its most vital feature for the emerging technology sector. This provision addresses a fundamental market friction: the most research-intensive firms, often in their early stages, frequently generate substantial tax credits but remain in a net-loss position for years, rendering non-refundable credits dormant. By allowing for the assignment of these credits, the Commonwealth effectively converts future tax savings into immediate working capital, turning a tax incentive into a form of indirect, performance-based grant funding.

Legislative Evolution of the Assignment Provision

The trajectory of the Pennsylvania R&D tax credit highlights a progressive shift toward greater liquidity and accessibility for innovators. The program was inaugurated by Act 7 of 1997, which created Article XVII-B to encourage taxpayers to increase research expenditures within the Commonwealth. At its inception, the credit was a traditional non-refundable incentive with limited transferability. The pivotal transformation occurred with the passage of Act 46 of 2003, which established the Research and Development Tax Credit Assignment Program. This legislation was specifically designed to assist the growth of technology-oriented businesses, particularly small startups, by allowing them to sell unused credits on the open market.

Initially, Act 46 imposed a "one-year holding period," stipulating that a business could only apply to assign its credits if they had not been used within one year of their approval by the Department of Revenue (DOR). This restriction was intended to ensure that the original awardee had a genuine opportunity to use the credit before seeking a market-based exit. However, as the fast-paced nature of the technology sector became more apparent, the legislature recognized that a one-year delay in accessing capital could be detrimental to a startup’s survival. Consequently, Act 48 of 2009 removed this holding period for credits awarded in 2009 and later, permitting immediate sale upon approval.

The commitment to the program has further been signaled by consistent increases in the annual credit cap. What began as a $15 million annual pool has expanded significantly to meet growing demand.

Table 1: Historical Progression of the Pennsylvania R&D Tax Credit Cap

Legislation	Period of Effect	Total Annual Program Cap	Small Business Set-Aside
Act 7 of 1997	1997 – 2003	$15.0 Million	$3.0 Million
Act 46 of 2003	2004 – 2005	$30.0 Million	$6.0 Million
Act 116 of 2006	2006 – 2008	$40.0 Million	$8.0 Million
Act 48 of 2009	2009 – 2010	$20.0 Million / $18.0 Million	$4.0 Million / $3.6 Million
Act 26 of 2011	2011 – 2021	$55.0 Million	$11.0 Million
Act 53 of 2022	2022 – Present	$60.0 Million	$12.0 Million

Further legislative refinements, such as Act 25 of 2021, introduced an appeals process for taxpayers and brokers concerning the administration of these credits, ensuring that the assignment process is governed by a robust legal framework that protects all participants. Act 53 of 2022 not only increased the cap but also mandated that the program cap remain fixed through June 30, 2025, providing much-needed regulatory stability for businesses planning multi-year research projects.

Technical Definition of Qualified Research and Expenditures

The Pennsylvania R&D tax credit relies heavily on federal definitions to maintain consistency and ease of compliance for multi-state taxpayers. The "Pennsylvania qualified research and development" is defined by reference to Section 41(d) of the Internal Revenue Code (IRC), with the critical caveat that the research must be conducted within the Commonwealth. This geographic nexus is fundamental; a Pennsylvania-based company cannot claim the credit for R&D activities performed in its New Jersey or Delaware facilities.

The Four-Part Test in the Commonwealth

To qualify for the credit, and by extension the ability to assign it, research activities must satisfy the "Four-Part Test" developed by Congress and adopted by the Pennsylvania Department of Revenue. This test ensures that the incentive targets genuine technological innovation rather than routine business improvements.

• Elimination of Uncertainty: The activity must be intended to discover information that would eliminate uncertainty regarding the capability, method, or appropriate design for developing or improving a product or process.
• Process of Experimentation: The taxpayer must evaluate one or more alternatives through modeling, simulation, systematic trial and error, or other scientific methods.
• Technological in Nature: The process of experimentation must fundamentally rely on the principles of physical or biological sciences, engineering, or computer science.
• Qualified Purpose: The research must relate to a new or improved business component's function, performance, reliability, or quality.

Categories of Qualified Research Expenses (QREs)

The credit is calculated based on specific expenditures incurred during the conduct of qualified research. Understanding these categories is essential for sellers to maximize their credit award and for buyers to evaluate the underlying asset they are purchasing.

• Wages and Salaries: This includes the compensation paid to employees directly engaged in research, as well as those providing direct supervision or direct support of the research activities.
• Supplies and Materials: The cost of tangible property, other than land or depreciable property, that is consumed or used in the research process. Examples include chemicals for lab testing or materials used to construct prototypes.
• Contract Research: Fees paid to third-party contractors to perform qualified research on behalf of the taxpayer. In alignment with federal rules, only 65% of these expenses typically qualify for the credit.
• Computer and Cloud Costs: Rental or lease costs for computers used in the research, including modern cloud computing and storage platforms dedicated to R&D activities.

It is important to note that capital equipment, general office supplies, and administrative costs do not qualify as QREs. The Pennsylvania program also requires that the taxpayer have at least two years of R&D spending history to be eligible for the credit, as it is an "incremental" credit intended to reward growth in research investment.

Calculation Methodology and Small Business Incentives

The Pennsylvania R&D tax credit is calculated using an incremental method that resembles the federal Alternative Simplified Credit (ASC). The credit is not based on total R&D spend, but on the increase in spending over a historical "base amount."

Determining the Base Amount

The base amount is generally calculated as the greater of:

• 50% of the Pennsylvania qualified research expenses for the current taxable year.
• The average Pennsylvania qualified research expenses for the four preceding taxable years. If the taxpayer has fewer than four years of history but at least one year, the average is based on the years available.

The credit is then applied to the "excess" QREs—the amount by which current-year spending exceeds the base amount.

The Small Business Advantage

Pennsylvania provides a significant structural advantage for small businesses to encourage early-stage innovation. A "small business" is defined as a for-profit corporation, LLC, partnership, or proprietorship with a net book value of assets totaling less than $5 million at the beginning or end of the taxable year.

Small businesses are entitled to a credit rate of 20% on their excess QREs, which is double the 10% rate provided to larger corporations. Furthermore, the Commonwealth reserves a specific portion of the annual cap—currently $12 million—exclusively for small business applicants. Historically, small businesses have been more likely to receive 100% of their requested credits, while non-small business awards are frequently prorated due to oversubscription of the general pool.

Table 2: Comparative Credit Calculation Metrics

Metric	Non-Small Business	Qualified Small Business
Asset Threshold	≥ $5 Million	< $5 Million
Credit Rate	10% of excess QREs	20% of excess QREs
Set-Aside Pool	$48 Million	$12 Million
Historical Proration (2024)	41.1% of requested	100% of requested
Carryforward Period	15 Years	15 Years
Transferability	Yes (Sale/Assignment)	Yes (Sale/Assignment)

The Procedural Framework for Credit Assignment

The sale of an R&D tax credit is a bifurcated process involving both the Department of Revenue (DOR) and the Department of Community and Economic Development (DCED). The DOR is responsible for the technical audit and award of the credit, while the DCED manages the administrative approval of the assignment.

The Award Phase: Application via myPATH

Before a credit can be assigned, it must be earned and officially awarded. Taxpayers must submit an annual application through the DOR’s myPATH online filing system. The application window opens on August 1 and closes on December 1 of the year following the tax year in which the expenses were incurred.

The application requires granular project-level data, including:

• Project names and physical locations in Pennsylvania.
• Specific breakdowns of direct wages, supplies, and contract labor for each project.
• Detailed technical narratives describing the elimination of uncertainty and the process of experimentation.
• A list of all owners with a 20% or greater interest in the entity, as well as officer information.
• Federal Form 6765, which provides the baseline for the R&D calculation.

Following the December 1 deadline, the DOR reviews all applications simultaneously. By May 1 of the subsequent year, the Department notifies applicants of their approved credit amount. It is only after this notification that the assignment process can begin.

The Assignment Phase: Form DCED-RD-009

To sell an unused credit, the "Seller" (Assignor) and the "Buyer" (Assignee) must jointly file the "Application to Assign Research and Development Tax Credits" (Form DCED-RD-009) with the DCED. This form serves as the legal notification of the transfer and requires disclosure of:

• The seller's identification and tax compliance status.
• The buyer's identification and PA Revenue ID.
• The specific credit being assigned (award date and amount).
• The dollar amount agreed upon for the transfer.
• Identification of any brokers or facilitators and the fees paid to them.

The DCED Technology Investment Office records the date of receipt, which becomes the "Date of Approval" for the assignment. This date is critical as it determines the taxable year in which the buyer must claim the credit.

The Role of Brokers and Market Value

Because of the specialized nature of these transactions, many businesses utilize registered tax credit brokers to connect with buyers. These brokers must be registered with the Department of Revenue. The secondary market for Pennsylvania R&D tax credits is robust, with high demand particularly in the manufacturing and technology sectors.

Historically, the value retention for these credits has been exceptionally high. As of 2024, over $167 million in credits have been sold historically, with sellers retaining an average of 92.9% of the credit's face value. This narrow spread reflects the market's confidence in the Pennsylvania R&D credit as a reliable asset.

State Revenue Office Guidance for Sellers (Assignors)

The Department of Revenue provides strict guidance regarding the eligibility of a seller to participate in the assignment program. The most paramount requirement is full tax compliance.

Tax Clearance and Compliance

Act 43 of 2017 authorized the DOR to perform rigorous tax clearances on all applicants prior to the awarding of a credit and before the approval of a sale. A "seller" cannot assign a credit if they have any unpaid Pennsylvania state tax liabilities. Furthermore, all 20% or greater owners must also be in compliance. If a business is found to be non-compliant, the DOR may withhold approval of the sale until all outstanding reports are filed and debts are paid. The department reserves the right to conduct onsite audits at the physical address where records are kept to verify compliance and the validity of the R&D claims.

Reporting the Gain on Sale

The sale of a tax credit is considered a taxable transaction for Pennsylvania income tax purposes. Because the credit is awarded based on expenses already deducted (or to be deducted) on the taxpayer’s return, the "cost basis" of the credit for the seller is generally $0.

The seller must report the gross proceeds from the sale as a "gain on the sale, exchange, or disposition of property." This is reported on:

• PA-40 Schedule D for individuals and sole proprietors.
• PA-20S/PA-65 Schedule D for S-corporations and partnerships.
• PA-41 Schedule D for estates and trusts.

The seller is permitted to reduce the taxable gain by the amount of any commissions paid to an agent or broker to facilitate the sale. The acquisition date is the date the credit was awarded by the DOR, and the sale date is the date the assignment was consummated.

State Revenue Office Guidance for Buyers (Assignees)

The "Buyer" or "Assignee" of an R&D tax credit is subject to a different set of rules and limitations than the original awardee. These restrictions are designed to ensure that the credits are used to offset active tax liabilities within a specific timeframe.

The 75% Utilization Limitation

Perhaps the most critical restriction for a buyer is the 75% cap. A purchaser of an R&D tax credit may only use the credit to offset up to 75% of their qualified tax liability for a given tax year. This ensures that even corporations utilizing the secondary market to reduce their tax burden still contribute a minimum of 25% of their assessed liability to the Commonwealth's general fund.

The "Immediately Claim" Rule

Unlike the original awardee, who can carry forward unused credits for up to 15 taxable years, a buyer has no such luxury. The law requires that the buyer "immediately claim" the credit in the taxable year in which the purchase or assignment is made.

If the buyer’s tax liability is insufficient to use the full amount of the purchased credit within that year (subject to the 75% cap), the remaining portion is permanently lost. The buyer is explicitly prohibited from:

• Carrying the credit forward to future years.
• Carrying the credit back to prior years.
• Obtaining a refund for any unused portion of the purchased credit.
• Reselling or reassigning the credit to another party.

Buyer’s Reporting of the "Spread"

The buyer must also report a gain on their Pennsylvania tax return if they purchase the credit at a discount. For example, if a buyer pays $90,000 for a $100,000 credit, the $10,000 discount represents taxable income.

The buyer's reporting logic is as follows:

• Cost Basis: The actual purchase price paid plus any commissions.
• Sales Price: The full face value of the credit allowed or permitted to be applied to the return.
• Gain: The difference between the value used and the price paid.

The acquisition date for the buyer is the date the credit was purchased, and the "sale date" for tax reporting purposes is the tax year-end date (typically December 31) for the year in which the credit is applied.

The Good Faith Purchaser Doctrine

To protect the secondary market's liquidity, the Department of Revenue has established a "Good Faith Purchaser" policy. If it is subsequently determined that the original seller was not entitled to the credit (for example, due to a later audit of their R&D activities), the Department will generally not seek to recover the disallowed credit from a buyer who purchased it in good faith and for value. Instead, the Department will seek recovery directly from the original seller. This protection is vital, as it allows buyers to purchase credits with a high degree of certainty, provided they have performed basic due diligence on the seller's award letter and tax clearance status.

Guidance for Pass-Through Entities and Owners

Pass-through entities, such as S-corporations and partnerships, have a unique position in the R&D credit ecosystem. They can choose to utilize the credit at the entity level, sell the credit on the open market, or "pass through" the credit to their owners.

Election to Pass-Through (REV-1123 Logic)

If a pass-through entity chooses not to sell its credit but instead wants to provide the benefit to its shareholders or partners, it must make an election. While Form REV-1123 is specifically titled for the Educational Improvement (EITC) and Opportunity Scholarship (OSTC) credits, the Department of Revenue uses similar logic and online forms in myPATH for the R&D credit.

The "Pass Through My Restricted Credits" function in myPATH allows the entity to irrevocably assign the R&D credits to owners in proportion to their share of distributive income. Once passed through to individual owners, these credits:

• Must be claimed immediately in the taxable year of the transfer.
• Cannot be carried forward, carried back, or refunded.
• Cannot be sold or assigned by the individual owners.

This creates a critical strategic choice for the entity: selling the credit on the market often provides more immediate cash flow for the business itself, while passing it through provides a personal tax benefit to the owners.

Individual Reporting for PIT

Individual taxpayers who receive an R&D credit (either through a pass-through or by purchasing one) are reminded that they cannot file a joint Pennsylvania tax return (PA-40) if they wish to claim these restricted credits. Separate filings for the taxpayer and spouse are required. Additionally, they must enter the code "PA" in the credit description code box on PA-40 Schedule OC to identify the use of a purchased or assigned restricted credit.

Case Study: Application and Assignment in Practice

To synthesize these complex rules, consider the example of BioVanguard Research LLC, a biotechnology startup based in Philadelphia, and Keystone Manufacturing Corp, a large industrial firm.

Phase 1: Earning the Credit (BioVanguard)

In 2023, BioVanguard invested heavily in developing a new drug delivery system.

• 2023 Pennsylvania QREs: $1,000,000 (Wages: $700k, Supplies: $200k, Contract Research: $100k).
• Historical Average (2019-2022): $400,000.
• Asset Value: $2.5 Million (Qualifies as a Small Business).

Step 1: Calculate Base Amount

• 50% of current year QRE: $500,000.
• Historical Average: $400,000.
• Base Amount: $500,000.

Step 2: Calculate Tentative Credit

• Excess QRE: $1,000,000 - $500,000 = $500,000.
• Small Business Rate: 20%.
• Tentative Credit: $100,000.

Step 3: Award

BioVanguard applies via myPATH by December 1, 2024. In May 2025, it receives an award letter for the full $100,000 because the small business pool was not oversubscribed.

Phase 2: Assigning the Credit (The Sale)

BioVanguard is not yet profitable and cannot use the $100,000 credit against its own zero tax liability. It needs cash for lab equipment.

• BioVanguard finds Keystone Manufacturing Corp as a buyer through a registered broker.
• Sale Price: 92% of face value ($92,000).
• Broker Fee: $2,000.

Step 1: File Form DCED-RD-009

The parties jointly file the assignment application in June 2025. The DCED records the date of receipt as the Date of Approval.

Step 2: Seller's Tax Reporting (BioVanguard)

On its 2025 PA tax return, BioVanguard reports:

• Gross Proceeds: $92,000.
• Less Commissions: $2,000.
• Cost Basis: $0.
• Taxable Gain: $90,000.

Phase 3: Utilizing the Credit (Keystone Manufacturing)

Keystone Manufacturing has a 2025 Pennsylvania Corporate Net Income Tax (CNIT) liability of $200,000.

Step 1: Calculate Maximum Offset

Keystone is limited to offsetting 75% of its liability.

• Max Offset: $200,000 x 0.75 = $150,000.
• Since Keystone’s purchased credit ($100,000) is less than $150,000, it can use the entire credit to reduce its 2025 tax payment to $100,000.

Step 2: Buyer's Tax Reporting (Keystone)

On its 2025 PA tax return, Keystone reports:

• Cost Basis: $92,000 (the price paid).
• Sales Price (Value Used): $100,000.
• Taxable Gain: $8,000.

Keystone must ensure it claims this credit on its 2025 return. It cannot carry it forward to 2026.

Interaction with Federal Tax Law Changes (TCJA Section 174)

A significant emerging issue for the Pennsylvania R&D tax credit program is the 2017 federal Tax Cuts and Jobs Act (TCJA). Starting in 2022, Section 174 of the IRC required businesses to capitalize and amortize R&D expenses over five years (fifteen years for foreign R&D), rather than expensing them immediately.

Although this is a federal capitalization rule, it impacts the state credit in two ways:

• Credit Calculation Basis: Pennsylvania continues to calculate the R&D credit based on "qualified research expenses" as defined by the IRC. However, the Department of Revenue has clarified that for the state application, it uses the expenditure amounts that match those claimed on the federal R&D credit application (Form 6765), rather than the amortized portion reported on the income statement.
• Tentative Credit Trends: The DOR noted in its 2025 report that the decrease in tentative credits awarded in 2023 and 2024 may be partially attributable to shifts in federal tax law, as businesses adapt their tracking systems to the new capitalization requirements.

Compliance Oversight and Common Pitfalls

The Department of Revenue maintains a high level of oversight over the assignment program to prevent fraud and ensure that the Commonwealth's tax expenditures are justified by actual innovation.

Common Reasons for Denial of Assignment

Applications for credit assignment are frequently denied for procedural or compliance reasons:

• Late Filing: Missing the December 1 deadline for the initial award application is fatal. There is no provision for late submission.
• Non-Compliance of 20% Owners: Even if the entity is compliant, if a major shareholder has an outstanding personal tax debt or unfiled return, the DOR will deny the assignment.
• Incomplete Project Narratives: If the technical narrative fails to clearly describe the "Process of Experimentation," the DOR may reject the credit during the audit phase.
• Failure to Respond to Information Requests: If the DOR or DCED requests additional info or an onsite audit during the sale approval process, a failure to respond "promptly" will result in the denial of the request.

Table 3: Summary of Utilization and Assignment Rules

Feature	Original Awardee (Seller)	Purchaser (Buyer)
Carryforward	15 Years	None (Must use in year of purchase)
Carryback	Prohibited	Prohibited
Refundability	Non-Refundable	Non-Refundable
Resale	Can sell to 3rd party	Prohibited (Cannot resell)
Liability Offset	Up to 100% of liability	Up to 75% of liability
Tax Treatment of Sale	Taxable gain (Basis = $0)	Taxable gain on discount (the "spread")
Pass-Through Option	Yes (via REV-1123 logic)	No

Final Thoughts: The Strategic Value of the Assignment Program

The Pennsylvania Research and Development Tax Credit Assignment program represents a sophisticated integration of tax policy and economic development. By providing a mechanism for the monetization of non-refundable credits, the Commonwealth ensures that its primary innovation incentive is accessible to the very companies that are most likely to drive future economic growth: early-stage, research-intensive startups.

For the innovator, the program provides non-dilutive capital that can be reinvested into further research, personnel, and infrastructure within Pennsylvania. For the purchaser, it provides a predictable and vetted means of reducing state tax liability at a slight discount. The high historical retention of credit value and the rigorous oversight by the Department of Revenue and the DCED create a stable secondary market that is essential for Pennsylvania's reputation as a "home-grown" technology hub. However, the complexity of the "Four-Part Test," the 75% buyer limitation, and the "immediately claim" rule necessitate that all participants engage in meticulous tax planning and maintain a high standard of state tax compliance.